LEVATROP 2.5mg / ml perfusive solution concentrate medication leaflet

C01CX08 • levosimendan • Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants

Levosimendan is a medication used for the treatment of acute decompensated heart failure. It acts as a calcium sensitizer, improving myocardial contractility without increasing oxygen consumption.

The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.

Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.

Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.